These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 7966569

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Phorbol ester-inducible T-cell-specific expression of variant mouse mammary tumor virus long terminal repeats.
    Theunissen HJ, Paardekooper M, Maduro LJ, Michalides RJ, Nusse R.
    J Virol; 1989 Aug; 63(8):3466-71. PubMed ID: 2545916
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Endogenous tumor necrosis factor-alpha contributes to lymphoproliferation induced by simian immunodeficiency virus variant, SIVsmmPBj14.
    Hodge S, Novembre FJ, Dewhurst S.
    Immunol Lett; 1998 Aug; 63(1):49-51. PubMed ID: 9719438
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.
    Scala G, Quinto I, Ruocco MR, Mallardo M, Ambrosino C, Squitieri B, Tassone P, Venuta S.
    J Virol; 1993 May; 67(5):2853-61. PubMed ID: 8386279
    [Abstract] [Full Text] [Related]

  • 30. NF-κB Duplications in the Promoter-Variant HIV-1C LTR Impact Inflammation Without Altering Viral Replication in the Context of Simian Human Immunodeficiency Viruses and Opioid-Exposure.
    Dave RS, Ali H, Sil S, Knight LA, Pandey K, Madduri LSV, Qiu F, Ranga U, Buch S, Byrareddy SN.
    Front Immunol; 2020 May; 11():95. PubMed ID: 32076422
    [Abstract] [Full Text] [Related]

  • 31. Linker-scanning mutational analysis of the transcriptional activity of the human immunodeficiency virus type 1 long terminal repeat.
    Zeichner SL, Kim JY, Alwine JC.
    J Virol; 1991 May; 65(5):2436-44. PubMed ID: 2016766
    [Abstract] [Full Text] [Related]

  • 32. The NF-kappa B binding site is necessary for efficient replication of simian immunodeficiency virus of macaques in primary macrophages but not in T cells in vitro.
    Bellas RE, Hopkins N, Li Y.
    J Virol; 1993 May; 67(5):2908-13. PubMed ID: 8474179
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The tyrosine-17 residue of Nef in SIVsmmPBj14 is required for acute pathogenesis and contributes to replication in macrophages.
    Saucier M, Hodge S, Dewhurst S, Gibson T, Gibson JP, McClure HM, Novembre FJ.
    Virology; 1998 May 10; 244(2):261-72. PubMed ID: 9601497
    [Abstract] [Full Text] [Related]

  • 35. Nucleotide substitutions in the long terminal repeat are not required for development of neurovirulence by simian immunodeficiency virus strain mac.
    Stephens EB, Sahni M, Leung K, Raghavan R, Joag SV, Narayan O.
    J Gen Virol; 1998 May 10; 79 ( Pt 5)():1089-100. PubMed ID: 9603323
    [Abstract] [Full Text] [Related]

  • 36. Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat.
    Duh EJ, Maury WJ, Folks TM, Fauci AS, Rabson AB.
    Proc Natl Acad Sci U S A; 1989 Aug 10; 86(15):5974-8. PubMed ID: 2762307
    [Abstract] [Full Text] [Related]

  • 37. Evolution of the human immunodeficiency virus type 1 long terminal repeat promoter by conversion of an NF-kappaB enhancer element into a GABP binding site.
    Verhoef K, Sanders RW, Fontaine V, Kitajima S, Berkhout B.
    J Virol; 1999 Feb 10; 73(2):1331-40. PubMed ID: 9882338
    [Abstract] [Full Text] [Related]

  • 38. The c-rel protooncogene product represses NF-kappa B p65-mediated transcriptional activation of the long terminal repeat of type 1 human immunodeficiency virus.
    Doerre S, Sista P, Sun SC, Ballard DW, Greene WC.
    Proc Natl Acad Sci U S A; 1993 Feb 01; 90(3):1023-7. PubMed ID: 8430069
    [Abstract] [Full Text] [Related]

  • 39. Inhibition of human immunodeficiency virus type 1 replication by a Tat-activated, transduced interferon gene: targeted expression to human immunodeficiency virus type 1-infected cells.
    Su Y, Popik W, Pitha PM.
    J Virol; 1995 Jan 01; 69(1):110-21. PubMed ID: 7983701
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.